Form 4 Filing for Ian Lawrence Turner

This filing details Ian Lawrence Turner's recent transactions involving options for Radiopharm Theranostics Ltd ordinary shares. Several grants of options are noted, with specific vesting dates and exercise prices, some contingent upon continued directorship or achievement of milestones. For instance, options granted on December 12, 2025, with an exercise price of 0.025, will vest in installments through July 1, 2028, provided Mr. Turner remains a Director. Other options, such as those granted on December 16, 2024, with an exercise price of 0.060, have vesting dates in September 2026 and September 2027, also contingent on his directorship. Some options have exercise prices as low as 0.025 and as high as 0.20. The filing also reports direct ownership of 6,985,292 ordinary shares and indirect ownership of 3,000,000 ordinary shares through a trust.